valproic acid analog (Jazz Pharmaceuticals)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Namevalproic acid analog (Jazz Pharmaceuticals)
Drug Alias Namepropylisopropyl acetamideKEY-12
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGamma-amino-N-butyrate transaminase inhibitorsHistone deacetylase 1 degraders
TargetsGamma-amino-N-butyrate transaminaseHistone deacetylase 1
Therapy Area/IndicationsBipolar DisorderEpilepsy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesJazz Pharmaceuticals Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesJazz Pharmaceuticals Plc
Active IndicationsN/A
Inactive IndicationsBipolar DisorderEpilepsy

Other Information

ATC CodeN/A
Related LinksN/A